• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Possible new avenue for drug development affecting multiple diseases

August59

Daughters High School Graduation
Messages
1,617
Location
Upstate SC, USA
This study showed up a couple of weeks ago, but I'm just getting around to posting it due to the holidays. It got my attention due to the subject is "misfolded proteins".

http://www.sciencedaily.com/releases/2013/12/131209181101.htm

I know Dr. Baraniuk's studies have noted the presence of misfolded proteins in CSF of ME/CFS patients. The attached study references them under the "Amyloid Proteins:" section in this study.

http://phoenixrising.me/research-2/...roteins-on-the-brain-spinal-tapping-for-mecfs

There was another study recently posted here that referenced "misfolded proteins", but I can't remember which one or who the author was. Misfolded proteins seem to be prevalent in many diseases, but were never a target for treatment. This could possibly change in the very near future as this has got to get the attention of the pharmaceutical companies now.

Could a phase or step in the creation or effects of misfolded proteins cause a significant change in ME/CFS at the approximately 3 year point in the disease?